Top Biotechnology Startups in 2024

Ark is developing novel cultivated meat infrastructure to unlock cultivated meat production at scale. We develop massive bioreactors and advanced automation technologies (e.g., digital twins) to enable previously unimaginable scale at a fraction of the cost of legacy solutions.

At 4Catalyzer we strive to transform 21st century medicine by solving today’s most challenging problems – across life science research tools, medical devices and therapeutics. We aspire to create significant societal impact and are motivated by the idea that our products will change the lives of people we love. Fundamentally, we are focused on developing new types of sensors and pairing them with deep learning to get a window into biology and medicine that nobody has ever had before. We have audacious plans – but we have an unbeatable team and a founder that has disrupted biomedical science successfully more than once. If you have experience in image reconstruction, mixed-signal IC design, high-speed electronics, nanophotonics, microfabrication, MEMs, biophysics, biochemistry, molecular biology, deep learning, cloud computing, embedded systems, or hold any dual degree with distinction along with computer science please contact us and “put a dent in the universe”.

Freenome is on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent diseases. If you crave challenges, understudied problems, and the chance to see your work impact the millions of lives touched by cancer, there’s no better place to be. We are committed to our core values of empathy, integrity, and trust enable us to push through challenges, learn from mistakes, and support one another to reach our fullest potential. By applying advanced ML techniques to recent breakthroughs in genomic science, Freenome is developing simple blood tests to detect early-stage cancer and make treatments more effective. The company has raised $238M from investors such as RA Capital, Polaris Partners, Perceptive Advisors, a16z, funds/accounts advised by T. Rowe Price Associates, Inc., GV (fka Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society’s BrightEdge Ventures, Data Collective Venture Capital, & Verily Life Sciences.

Each year, biomedical researchers waste over a billion hours trying to communicate their research by drawing complex biology figures using tools like PowerPoint. These products weren’t built for scientists so are very time consuming and produce poor quality results. What’s worse, if you google any biological concept you’ll find hundreds of figures that look very different but are trying to communicate the exact same thing. At BioRender, our mission is have every visual representation of biology made and communicated with our tools. We reduce the time it takes scientists to create visuals from hours to minutes while drastically improving the quality. We save scientists 10-20 hours per month, giving them more time for the important stuff!

Karius is a life sciences company focused on generating genomic insights for infectious diseases with a non-invasive karius® test that helps clinicians make rapid treatment decisions. our laboratory is clia-certified and cap-accredited to perform high-complexity clinical laboratory testing. we provide unique genomic insights by detecting microbial cell-free dna (mcfdna) circulating in the bloodstream from pathogens causing an acute infection. proprietary technology efficiently extracts mcfdna directly from blood and depletes the strong human background signal and environmental contaminants. advanced machine learning algorithms allow analysis of complex genomic data in real-time. proprietary reference genome databases are constantly refined as more data becomes available.

Tempus is a technology company that has built an operating system to battle cancer. Tempus enables physicians to deliver personalized cancer care through its interactive analytical and machine learning platform. The company provides genomic sequencing services and analyzes molecular and therapeutic data to empower physicians to make real-time, data-driven decisions. Our goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as we gather more data.

Synthego’s vision is to turn biology into an information science, with the ultimate goal of dramatically extending the healthy human lifespan. Synthego builds advanced bioinformatics and automated hardware platforms to create next-generation molecular biology tools, starting with full-stack genome engineering. These world-class tools accelerate basic scientific discovery, critical disease cures and novel synthetic biology applications to improve and prolong life.

Nucleus is building a DTC genetic testing platform that provides innovative genetic risk and disposition score analyses on an extensive number of diseases and traits by leveraging whole-genome sequencing (WGS). Nucleus provides WGS genetic testing kits for users to receive rare variant analysis and polygenic scores across a wide variety of diseases and traits — ranging from breast cancer risk to longevity disposition. Individuals who have done DTC microarray genetic testing from companies such as 23andMe can upload their genotyped DNA on the Nucleus platform to receive a subset of the possible genetic analyses, centering around polygenic scores. These scores are calculated by combining the effects of hundreds, thousands, or even millions of DNA letters that vary from one individual to another.

We’re a growing company. Everything we do, we do to help people grow into the best version of themselves. As the pioneers of hair wellness, we create natural, clinically effective formulas for hair growth and provide support for people at every step of their hair journey. Our multi-factorial approach targets the root causes of hair thinning using a patented blend of medical-grade botanicals—and is recommended by over 3,000 physicians and hair professionals for trusted, reliable results. We never settle, and are continuously challenging existing treatments and methodologies to advance the frontier of hair science. As we help our customers grow, we grow too—by embracing individuality and differences, leading by example, and empowering ourselves and others with our passion for wellness and innovation. Keep growing. It’s our mantra. Our commitment to helping anybody and everybody committed to realizing their own potential to grow.